APA (7th ed.) Citation

Schaper-Gerhardt, K., & Utikal, J. (2018). PD-L1 status does not predict the outcome of BRAF inhibitor therapy in metastatic melanoma. European journal of cancer, 88, . https://doi.org/10.1016/j.ejca.2017.10.026

Chicago Style (17th ed.) Citation

Schaper-Gerhardt, Katrin, and Jochen Utikal. "PD-L1 Status Does Not Predict the Outcome of BRAF Inhibitor Therapy in Metastatic Melanoma." European Journal of Cancer 88 (2018). https://doi.org/10.1016/j.ejca.2017.10.026.

MLA (9th ed.) Citation

Schaper-Gerhardt, Katrin, and Jochen Utikal. "PD-L1 Status Does Not Predict the Outcome of BRAF Inhibitor Therapy in Metastatic Melanoma." European Journal of Cancer, vol. 88, 2018, https://doi.org/10.1016/j.ejca.2017.10.026.